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2. 
PSYCHOPHYSIOLOGICAL TENSION IN MENSTRUATION 
INTRODUCTION 
This problem of menstruation is seemingly well 
known, but in reviewing the literature one is impressed 
with the scarcity of good information. At the present time, 
the greatest amount of information is descriptive in nature 
and usually goes under the name of lithe premenstrual syndrome." 
The explanations for this syndrome, whether psychological 
or physiological, are numerous, but exploration of the 
problem has been of minor significance and incomplete. Infor-
mation about attempts at treatment is scanty and conflicting. 
One major problem is the small scale of the previous investi-
gations and the lack of coordinated studies. An attempt 
will be made in this paper to summarize the findings of 
previous investigations as reported in the literature in 
order that the overall complexion of the problem can be 
assessed. 
DEFINITION AND OCCU~NGE 
The term "premenstrual syndrome fl was originally 
used by Frank in 1931, but in 1963 Coppen proposed the use 
5 
of the term "cyclic syndrome." His reasons were: (1) 
It dispenses with restriction in time imposed by the word 
premenstrual; (2) It draws attention to the fact that it 
is more likely to be related to pituitary activity, and 
thus complex hypothalamic and endocrine multiglandular 
interaction than merely to a basically pelvic disturbance; 
3. 
(3) It presents a concept of psychology rather than pathology 
with the inference that many features may occur which do not 
demand treatment. While no recent literature has disputed 
the term used by Coppen, the term premenstrual syndrome 
still prevails, probably by tradition. 
The premenstrual syndrome is not just a given set 
of symptoms and signs which must be found in a person to 
classify them as having the premenstrual syndrome. It 
contains many signs and symptoms, only a few of which 
need be combined to qualify for the syndrome. It is not 
a rare academic syndrome, either. Estimates vary that from 
25 to 100 percent of women have increased psychic and somatic 
disturbances during ovulation, premenstrually or menstrually. 
One of the most commonly quoted figures for women 
having premenstrual tension syndrome is 70 per cent. This 
figure was obtained by Eichner, using a group of student 
3 
nurses as controls in a questionnaire study. He found 
that 70 percent of the nurses had one or more of the common 
4 
symptoms of premenstrual tension. Morton using a group 
of female prisoners found that 80 percent of 249 had pre-
menstrual tension. As stated before, however, the figure 
varies from 25 to 100 percent, depending on which study is 
quoted and what definition of premenstrual sydrome is being 
used in that study. 
In their study of the premenstrual syndrome, 
Coppen and Kessel used a questionnaire to obtain information 
from 150 nulliparas. Their data revealed that 76 percent 
4. 
5 
had regular menses. The mean duration was 4.8 days and 
54 percent contained clots. There was no pain reported 
in 17 percent, 47 percent reported pain in the premenstrum, 
and 66 percent had pain with menstruation. In the group 
with premenstrual tension, premenstrual pain was found in 
12 percent, menstrual pain in 25 percent. Other common 
complaints menstrually or premenstrually are given in 
Table I. 
Not all findings are subjective during premenstrual 
8 
tension. Goldfarb, in a pamphlet on premenstrual tension, 
lists the following objective findings: glycemia, neutro-
philia, lymphocytopenia, suppression of capillary resistance, 
digital sweating and increased sensitivity of the respiratory 
center. What the above shows is what Coppen, Dalton and 
others have come to agree on, that any combination of the 
above occurring cyclincally constitute what can be called 
"the Premenstrual Syndrome." See Table II. 
PSYCHOLOGICAL ASPECTS 
To illustrate some of the psychological overtones 
associated with the menstrual cycle and menstruation in 
particular, Dalton divided a 28 day month into seven 
four-day periods. She then measured the time of admission 
of 276 female acute psychiatric patients. The expected 
probability was 14 percent during any four-day period. 
Dalton found 28 percent admitted during menstruation and 
17 percent in the four days prior to menstruation. Of 36 
attempted suicides, 39 percent were during menstruation and 
14 percent were premenstrually. Depression accounted for 
TABLE I 
COMPLAINTS: MENSTRUALLY AND PREMENSTRUALLY 
1) Cyclical acneform eruption 70% 
2) Irritability 69% 
3) Depression 63% 
4) Swelling in some part of body 63% 
5) Headache 32% 
6) Constipation 20% 
7) Dizziness 16% 
8) Diarrhea 13% 
9) Insomnia 5% 
10) Spots before eyes 2% 
The above list of symptoms has been confirmed 
numerous times although there may be variations 
in the frequency of occurrence of different 
5. 
symptoms. Greenblatt lists irritability, depression, 
insomnia, headaches, breast turgidity, premenstrual 6 
edema, and nausea as the seven most common symptoms. 
A study by Hood and Bond yielded the following 
7 
figures for premenstrual symptoms. 
TABLE II 
SYMPTOMS OF PREMENSTRUAL SYNDROME 
No. Of 
SlmEtom Patients Percent 
Irritability 25 100 
Headache 23 92 
Bloating 22 88 
Breast engorgement 21 84 
Nausea 15 60 
Abdominal cramping 14 56 
Edema 11 44 
Acne 9 36 
6. 
7. 
185 patients, and, of this group, 33 percent were menstru-
ating and 14 percent were premenstrual at the time of 
admission. Of 114 with an admitting diagnosis of schizo-
phrenia, 26 percent were menstruating and 21 percent were 
9, 10 
premenstrual. 
In another study, Dalton found that of 156 female 
prisoners, 28 percent committed the crime while menstruating 
and that 22 percent of the crimes were premenstrual. A 
study using autopsy material revealed that of 22 Hindu 
women committing suicide by fire, 19 of the women were 
12 
menstruating. The amount of data could probably be end-
less in proving that there is often psychological tension 
associated with menstruation and in the premenstrual period, 
but the question is, why? The reasons given for the premen-
strual syndrome range from strictly psychological to physio-
logical, which most commonly involves hormonal studies. 
The most commonly accepted psychological view 
"indicates that the perception of her menstrual flow inten-
sifies a woman's pre-existing conscious and unconscious con-
flicts about pregnancy, having a child, castration fears, 
uncleanliness, lack of control of bodily functions, aggression, 
penis envy and masturbation. In the presence of a vulnerable 
ego structure; neurotiC, psychotic or characterological 
reactions may occur. In most women the compensation for the 
deprivations associated with femaleness is the process of 
pregnancy and the bearing of a child. Hence, the common 
psychoanalytic observation that a menstrual period is 
13 
experienced as a "lost child." 
8. 
Some people, while realizing the above explanation 
and accepting it, have added to it more of the environmental 
aspects of life. Mary Chadwick, who wrote the book, The 
Psychological Effects of Menstruation, devotes one chapter 
to the common tribal taboos associated with menstruation. 
The book points up some interesting aspects which have not 
been fully studied, but which can be speculated about. An 
example was the fact that people in Brunswick thought IIthat 
if a menstruous woman assists at the killing of a pig the 
14 
pork will putrefy." What effect did this have, and what 
effects do similar taboos of the past or present have on 
women today? 
Some investigators have continued a step further 
and correlated the psychology with the physiology. One 
such study indicates that estrogen correlates to hetero-
sexual tendency, masculine identification and infantile 
tendencies. Progesterone was correlated to homosexual tendency, 
narcissism, mother conflict, pregnancy and nursing tendencies. 
Low hormone levels were matched with dependence, depression 
and withdrawal, anal and genital elimination tendency and 
15 
a destructive tendency. 
The most commonly studied psychological factor 
relates to neuroticism. Rees found that the premenstrual 
syndrome was associated more frequently with neurotic 
indiViduals and that neuroticism is also higher in women 
9. 
with irregular periods. Rees made the following concluding 
statement, "It appears women who complain of premenstrual 
irritability are irritable at other times as well and it 
seems therefore, that menstrual symptoms are exacerbations 
of personality traits which in turn are related to 
16 
neuroticism." 
To illustrate the above point, a study done by 
17 
Irwin Perr serves appropriately. (Table III). 
The major conclusion to be drawn from the preced-
ing study was admirably stated by Suaiez-Murias when he 
18 
wrote, "The psychologic aspect of premenstrual tension 
seems related largely to the manner in which the patient 
accepts psychically the menstrual function and also to the 
manner in which the patient unconsciously utilizes the 
menstrual function to express distress about pressing 
environmental situations of life, difficult interpersonal 
relationships, or about her own attitude concerning being 
a woman, or even about the fact of existence." In other 
words, personality type and environmental setting are the 
real factors in the psychologic manifestations of premenstrual 
20 
tension. Israel, one of the foremost writers on the 
premenstrual syndrome, stated this exact thought as follows: 
"Irrespective of the exacting mechanisms it cannot be 
denied; because of the nature of the symptoms, that emotional 
disturbances and psychogenic traumata not only aggrevate 
the symptoms, but evoke additional ones." 
TABLE III 
INCIDENCE OF PREMENSTRUAL TENSION 
IN NORMALS AND NEUROTICS 
10. 
Degree of Tension 
None 
Normals (61) Neurotics (84) 
Moderate 
Severe 
78.7% 
16.4% 
5.0% 
38% 
30% 
32% 
THE INCIDENCE OF PREMENSTRUAL TENSION RELATED TO 
DEGREE OF NEUROTIC CONSTITUTION 
Degree of Neurotic 
Constitution 
Nil 
Mild 
Severe 
Degree of Premenstrual Tension 
Nil or Mild Moderate Severe 
16% 
56% 
15% 
17% 
36% 
48% 
7% 
8% 
37% 
11. 
PHYSIOLOGICAL ASPECTS 
"That pathologic emotional findings are bio-
chemically influenced is widely accepted. Speculations as 
to etiology are reviewed in Southam's article and include 
sodium and water retention, excess of aldosterone, allergy 
to progesterone and its metabolities, a menstrual toxin, 
20 
excessive antidiuretic substance and hypoglycemia. 
An increase in mineral corticoids and glucocorticoids in 
relation to ovarian steroids, a high estrogen-progesterone 
ratio and effect of adrenocortical hormones in general 
2 
have also been suggested as etiologic factors. 
The most widely accepted physiological explanation 
for tension during the menstrual cycle is sodium retention 
and its accompanying water retension. One study showed 
that of 42 normally menstruating women, 30 percent gained 
three or more pounds premenstrually. It is felt that the 
water and sodium retention secondarily may cause lowering 
of nerve activation thresholds and thus more nervous system 
irritability. The lowered threshold is manifested clinically 
by a weakening of ego controls according to the characteristics 
21 
of the predisposing personality structures. 
The increased fluid retention or increased steroids 
at various times during the menstrual cycle have also been 
thought to cause relative hypoglycemia and thus psychiatric 
symptoms. Common symptoms associated with hypoglycemia are 
depression, insomnia, anxiety, irritability, fatigue, 
swea~ing, headache and dizziness. The hypoglycemia may 
? 
be due to decreased glucose tolerance from increased 
glucocorticoids or other steroids, possibly estrogen, 
22 
during the premenstrual period. 
23 
Thorn in 1938, did the classical work in the 
12. 
area of menstrual edema. He did a study in which he showed 
that out of 50 normal women, 24 (48 percent) gained one 
kilogram or more premenstrually and that 38 (76 percent) 
gained one kilogram or more about the time of ovulation. 
Thorn postulated this was due to increased hormones, probably 
estrogen. Using dogs and injecting sex hormones, Thorn was 
then able to assay the salt retaining property of these 
hormones. He found that the following had salt retaining 
property: (They are listed in decreasing order of potency.) 
1) Estradiol, 2) Progesterone, 3) Estrogen, 4) Pregnanediol, ~ 
5) Testosterone. It is very probable that estradiol accounts 
for much of the premenstrual fluid retention. 
Morton experimentally verified this by studying 
24 
29 patients with premenstrual syndrome. In these patients, 
he followed basal temperatures, endometrial biopsy, vaginal 
smears and urinary hormones, during the premenstrual phase 
in particular. Morton was unable to demonstrate an abrupt 
rise in temperature at midcycle, found proliferative or mixed 
endometrium, cornified vaginal cells and subnormal prenanediol 
excretion in 10 of 14 patients, indicating that estrogenic 
activity was much greater than progestational activity. 
Estradiol peaks at ovulation and in the premenstrual 
25 
phase and is often given as the cause for water retention. 
13. 
Morton suggests that it is actually the estradiol/progesterone 
26 
ratio that causes the water retention. In fact, the 
premenstrual syndrome has been induced in castrates and meno-
pausal patients by large doses of estrogen. 
The plausibility of the above theory is nicely 
explained in Drill's Textbook of Pharmacology 1965, and 
it also accounts for the implication that aldosterone is 
involved in the Premenstrual Syndrome. Drill states that, 
"Estrogens can promote sodium retention, with associated 
fluid retention and edema. This is more prone to occur 
only when high doses of estrogen are used. However, the 
effects of estrogen upon fluid retention are less severe 
than those seen after testosterone or glucocorticoid therapy. 
In all probability, it may be the decrease in progesterone 
level that is responsible for the fluid retention. Since 
progesterone displays anti-aldosterone activity, the lowered 
progesterone secretion level permits aldosterone, which 
increases at this time to induce fluid retention." Gluco-
corticoids have also been implicated because they have many 
27 
of the water retention properties of mineralcorticoids. 
That aldosterone is indeed elevated in the 
luteal phase of the menstrual cycle has been demonstrated by 
Strausfeld. He demonstrated that aldosterone secretory rates 
range between lOO~g during the follicular phase in females, 
r' 
while during the luteal phase the range is between 23cr~g 
and 350~g. The rates in the luteal phase were all outside 
the normal range for a male. In one woman with premenstrual 
tension, the luteal secretory rate was five times that 
14. 
28 
found in the follicular phase. An additional cog in the 
wheel is the fact that emotional stress can activate the 
adrenal cortex in man, thus increasing steroid levels in 
29 
the peripheral blood. The question arises, however, 
as to how much stress menstruation causes? 
One last hormone should be mentioned as a possible 
cause of fluid retention, i.e. antidiuretic hormone (ADH). 
Although ADH has not commonly been discussed as a cause 
30 
for premenstrual tension, Pendergrass did an interesting 
experiment involving irradiation of the posterior pituitary 
in humans. He felt that ADH may cause premenstrual tension 
and therefore he irradiated the pituitary glands of women 
with fluid retention premenstrually. Initial success was 
noted in approximately 50 percent of his cases. One-third 
of the cases had no ADH substance in the urine following 
irradiation. A point not fully explained in this study is 
the method or feasibility of destroying only the ADH 
producing center. What else may have been involved? 
Of final significance in the etiology of 
premenstrual tension is the theory of Macht and others 
who feel that the pathology is caused by a toxin, "the 
31 
menotoxin!' Macht felt the "menotoxin" was toxic to 
both plant and animals and was found circulating in the 
blood at the time of the menses. He proposed that the 
"menotoxin" was closely related pharmacologically to the 
phenanthrene derivatives, cholesterol and oxycholesterol, 
although it was a separate entity. The possibility that 
the "menotoxin" was a breakdown product of the steroid 
hormones was included as a possible origin. 
15. 
TREATIVIENT 
Treatment of the premenstrual syndrome has been 
aimed mainly at the problem of fluid retention. Low salt 
diets, diuretics and lithium have been used, but they do not 
seem to be of significant value. Progesterone may be one 
of the most useful preparations in the premenstrual syndrome 
because of its action as an antagonist of aldosterone. 
Other ideas which have been tried but which showed little 
25 
promise are androgen, vitamins, and oophorectomy. 
The best studied of the theraputic regimens for 
the premenstrual syndrome seems to be the so called'multi-
R 
demsional" approach. This is a preparation (Pre-Mens ) 
composed mainly of ammonium chloride as a diuretic, homa-
tropine and a number of vitamins, Vitamin B complex being 
the main vitamin. Vitamin B. complex deficiency supposedly 
affects the ability of the liver to destroy estorgens which 
are probably an important causative factor in premenstrual 
32 
tension. Homatropine acts as an antispasmodic. 
Morton's study of 249 female prisoners with 
premenstrual tension indicated that: 
1) 15 percent of inmates reported improvement 
when given placebos. 
2) 30 percent of inmates reported improvements 
with placebos and high protein diet. 
R 
3) 61 percent of inmates given Pre-Mens only 
improved. 
4) 79 p~rcent of inmates improved when given 
Pre-Mens plus high protein diet. 
16. 
R 
Thus, from this study, Pre-Mens seem to be quite effective. 
Eichner and Waltner demonstrated 50 percent of 86 women 
R 32 
had a complete relief of congestive symptoms with Pre-Mens • 
Many had partial improvement. 
Although ammonium chloride is thought to be the 
R 
main functional chemical in Pre-Mens , Eichner has shown that 
the "multidimensional" tablet is superior to ammonium chloride 
33 R 
alone. Pre-Mens has also produced improvement of the 
acne associated with the Premenstrual Tension Syndrome. In 
one study, 42 of 50 patients improved; 33 improved markedly. 
R 
Pre-Mens worked three times better than ammonium chloride 
34 
alone. 
Other diuretic preparations have also been used 
to treat the ~remenstural syndrome, although none have been 
so well studied as ammonium chloride. Of the other diutetics, 
the thiazides have been bes't studied, but much more informa-
tion is needed. One of the few studies available was done 
35 
by Bushnell. In this study the author gave 36 patients 
with symptoms of premenstrual tension 5 to 7.5 mg. of 
methyclothiazide each day during the ten day period prior 
to the onset of menses. After continuing treatment over 
a one to five year period, the author observed that symptomatic 
response was excellent in 15 patients; good in 20; and fair 
in one. Similar results may be found in the works of 
36, 37 
Winshel and Shabanah. Shabanah recorded weight losses 
of from two to ten pounds in 72 hours. Taking these reports 
into account, the thiazide diuretics may be as good as 
R 
Pre-Mens and better than annomium chloride. It should 
b~ noted that while the diuretics often totally relieved 
symptoms of premenstrual tension, they were best at 
relieving the symptom of pelvic congestion. 
The second major group of agents used to treat 
the premenstrual syndrome are the hormones. Many have 
17. 
felt that they are the answer, since very probably estrogen 
is a causative factor in premenstrual tension. It now 
becomes apparent that they are only partially the answer. 
Even the proposed cause of the syndrome, estrogen, has been 
tried as a method of treatment, and with reported success. 
In a number of cases they seem to be of help. Greenblatt 
feels that simple estrogens, like estriol, help but complex 
6 
estrogens such as estradiol may aggrevate the condition. 
No well planned experimeni1f: have been carried out to investi-
gate this problem. 
Progesterone has been studied much more than 
estrogen as a method of treatment for the premenstrual syndrome. 
Altl!ough it has not been proven conclusively, that 
women with premenstrual tension are relatively deficient 
in progesterone, this is a generally accepted theory. Hence, 
people have used progesterone as treatment. 
R 
Enovid (norethynodrel with added ethinyl estradiol) 
has been one of the best studied progestational agents. 
R 
Heller and Hood have both confirmed that Enovid relieves 
18. 
38, 7 
the premenstrual syndrome. Hood studied 25 patients 
R 
with premenstrual tension, each receiving Enovid as 
R 
The usual symptoms were noted and Enovid treatment. 
was used in the prescribed method. Of the 5 patients, 
21 obtained at least partial relief. Side effects were 
high, however. Nausea with the first treatment cycle was 
experienced by 22 patients, nausea in subsequent cycles 
by 8, breast engorgment in 22, and delayed menses in 11. 
R 
Although Enovid is of benefit in a high percentage of cases, 
Hood made the following comment in summarizing his study, 
"There appears to be no advantage over other therapeutic 
agents for the control of premenstrual tension." In fact 
the Food and Drug Administration has found this to be quite 
R 
true and does not recognize Enovid as treatment for 
premenstrual tension. (Refer to letter from Searle & Co. 
at the end of paper). 
Testosterone is the last of the hormones to 
be tried. Once again adequate studies have not been done, 
and one must follow impressions only. Enough has probably 
been said if one mentions that Greenblatt and Freed have 
both had good results with testosterone, although they 
39, 40 
found it may aggrevate water retention. 
Many other agents and methods for treating pre-
menstrual tension have been recommended over the years. In 
most cases these agents have been adopted empirically for 
use in premenstrual tension after studies have shown their 
value in relieving the same symptom when not associated with 
19. 
the premenstrual syndrome. Examples of this are the minor 
analgesics such as aspirin, the tranquilizers such as 
reserpine or the phenothiazines. All have been used in 
treating premenstrual tension and are often successful 
in relieving a specific symptom. Other drugs have been 
mentioned for treating the premenstrual syndrome such as 
Vitamin B to increase liver destruction of estrogen (studied 
R 
by Biskinds). Bellergal an autotomic depressant and anti-
spasmotic drug, which has been studied by Craig has also 
42 
been used. 
The best overall summary of the results of treat-
ment using many of the drugs discussed in this paper can 
be found in two charts from an article on the premenstrual 
33 
syndrome by Edward Eichner. A copy of the charts from 
this paper can be found on the following page. 
SUMMARY 
The premenstrual syndrome, while being a common 
problem, is also a bothersome one. The entity is well 
described and reduplicated in the literature, but as with 
many human functions, it is complex. Its causative factors 
are probably an interaction of psychic aspects and hormonal-
physiologic functions. Because of the complexity of the 
syndrome no one cause will probably be found and no one 
treatment will be the answer. 
CHART 1 
DIURETIC TREAT'IEr\T FOR PRE:\IE~STRUAL TE~SIO~ 
No. Satisfactory 
R, Dosage Patients ReSlllts 
Acetazolamide (DiamoxE) ______________ . ______ 0.125 - 1.0 Gm. Daily to Relief, 
Start with Symptoms 
Ammonium Chloride, Plain-coated __________ 4.0 Grn. Q.I.D. for -I Days, 
Start with Symptoms __ 
Hg - Theophylline Cmpd: 
(Cun1t'rtilinE Inject.) ___ _ 
(CumertilinE Oral Tah.) 
Aminometramide (\lictineE) 
Aminoisometradine (RolictonE) 
Ethoxzolamide (Carclrast:1':) 
____ 1 - 2 ce. Intragluteal, Once at Onset 
_ _______ 2 Tabs. Q. A\[ to Relief, Start \\'ith 
Symptoms _____________ ' ________ _ 
_______ . __ 1 Tab. Q.I.D.:3 D'lYS (less is inadequate) 
_1 Tab. Q.I.D. 2 Days, Then 1 Tab. B.I.D. 
15th Day Cycle to Onset of Flow _ 
__ 62.5 - 2.50 \lg. Dail~- :3 Days Starting with 
Onset of Symptoms _. ________________________ _ 
Hydrodllorothi.tzide (I I~ dr()(liurilft) 
62 .. ') - 2')0 \[g. Q.2.D. Starting IBth D. 
I Tall. ll.I.D. I.')th 1),1' til Onset of Flow, 
or Dllratioll S\llli,tollls 
To 1.\1. OF D" III II<" 
• 
CHART 2 
TREATI1E~T OF PRE:\lEr\STlWAL TE~SIO~ 
62 :3:3.9 
38 28.9 
15 40.0 
30 26.6 
.') 20.0 
:!:3 :39.1 
.') 40.0 
9 :'I ..... ;") 'J'),-) 
7 -- ) 'Ji .:.. 
19-1 :):)}) 
20. 
----
III 
Effects 
12.9 
IS.1 
6 .• 
10.0 
60.0 
8 .• 
40.0 
22.2 
2B.6 
I·U 
- -.-- - ~-- ---_._--. -- - - - -- _.- _ .. 
- -'--- '- -." ----,.- _. - --- ---_ .. -.-----------.--- ~---- ---------_._--
No. Satisf(Jctory 
Dosllge Patients Results 
DIET: '- Hi-Protein, Lo Sodilull 
ALL DIURETICS 
POLYl'JI:\I\\!:\CAL \IEDICATIO~: 
PrclIIl'llslc Plain 
Premcns \\'ith AlllphetalllinC® 
Premens with Reserpine 
Placebo Control 
Diamox Compound* 
. (200 \Ig. ~a Daily) Starting l.5th Day 
of Cycle _____________ . ___________ ._. ___ . ___ 347 
Scheduil' Constant for All Types 
2 Tah. "Ll.D. Starting with SYlllptoms. 
Discontinul' with Helief or in .5 Days. 
Restart 50S c Symptoms. 
194 
242 
2H 
121 
45 
"A", "B", '·C" _____________________________ 1 - 2 Caps. D'lily Starting 7 - 10 Days 
Before Expected Onset of FIO\\' __ _ 26 
Ethisterone Compound* __________________ l - 2 Tabs. Daily Starting 7 - 10 D'IYS 
SY~TIIETIC STEHOIDS 
Ethisterone Compuund 
Delalutin'l; 
Beforc Expl'cted Onset of ~'Io\\' __ 14 
SeC' I'olyplwrlllalotl \["dicatioll-Ill Effects Primarily 
JIea\'y or Prolollg(·d Blceding 
2.30 - :37.5 \[g. 1.\1. l:3tll - 18th D'l) 
Cyde __ ______________ 9 
1 Tab. 5th thru 2.5th D'l) Cycle, or _____ _ 
1 - 2 Tahs. Daily I.3th - 2.Sth Da) Cycle 
Braxorone _ ___ __________________________ .. 2 . 6 Tahs. Daih- .5th thm 2.5th D'lL 
7 
10 
.') 
6 2 - 6 Tabs. Dail;- l.5t1l - 2.5th Day C;'cle 
*Series incomplete 
1.5.3 
3:3 . .5 
8·U 
6-1.:3 
81.0 
8.8 
61.5 
.57.1 
22.2 
42.9 
50.0 
20.0 
50.0 
III 
Effects 
O.O'7c 
14.4 
.5.0 
42.8 
6.6 
11.1 
24.6 
42.8 
22.2 
28.6 
40.0 
40.0 
.", ., 
'.)'.).'), 
Prom Eichner, 
Dysmenorrhea, 
E., I'remen;c;trual 'rension Syndro;:''1e 
56:1-8 1960. 
and :Fri.::c:ary 
".1 '[' '.' d T 1!.,. 'l.r6· ~.~., 
\ 
\ 
I 
\ 
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Research in the Service of Medicine 
G. D. & CO. P. O. BOX 5110, CHICAGO, IlliNOIS 60680. Telephone (312)-463-21i1 
Mr. Richard D. Schmidt 
608 So. 38 St., Apt. 5 
Omaha, Nebraska 68105 
Dear Mr. Schmidt: 
January 2, 1969 
Many thanks for your letter of December 12 in which you 
request information concerning the use of Enovid for 
treatment of patients with premenstrual tension. 
Enclosed are several published reports in which you will 
be interested. Sometime ago, however, the Food and 
Drug Administration withdrew approval for recommending 
this cli~ical application of Enovid and our only current 
claims for this preparation are those described in the 
enclosed information leaflets for Enovid 10 mg, Enovid 
5 mg and Enovid-E. 
I hope you will find this material to be of assistance. 
very sincerely, 
21. 
J ~-\ / /"/~{ t:_./ '/J , . /" ( , /';7 ;/:::~ ~ C:)-C'-"'::'4-c'>?~~ 
I' J. William Crosson, M. D. 
, Assistant Medical Director 
JWC:vz 
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